Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3B
|
pubmed:dateCreated |
1994-9-22
|
pubmed:abstractText |
Childhood acute nonlymphoblastic leukemias (ANLL) of untreated patients were analysed for expression of thymidylate synthase (TS) using immunocytochemistry. Only patients who achieved a complete remission were entered into the study (n = 21 patients). Of the 21 ANLL, 11 showed an overexpression of TS. There exists a strong correlation between the expression of TS and the relapse rate (p = 0.029, Fisher's exact test). Only 3 out of 11 cases of TS-negative patients with ANLL relapsed whereas 8 out of 10 TS-positive cases experienced relapses. The relapse-free intervals of the patients with TS-positive leukemic cells were significantly shorter than those of patients with TS-negative leukemic cells (p = 0.025, log rank test). There was a trend for shorter overall survival times of patients with TS-positive leukemic cells compared with patients with TS-negative leukemic cells (p = 0.12).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1271-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8067695-Adolescent,
pubmed-meshheading:8067695-Child,
pubmed-meshheading:8067695-Child, Preschool,
pubmed-meshheading:8067695-Female,
pubmed-meshheading:8067695-Humans,
pubmed-meshheading:8067695-Immunohistochemistry,
pubmed-meshheading:8067695-Infant,
pubmed-meshheading:8067695-Leukemia, Myeloid, Acute,
pubmed-meshheading:8067695-Male,
pubmed-meshheading:8067695-Recurrence,
pubmed-meshheading:8067695-Retrospective Studies,
pubmed-meshheading:8067695-Survival Rate,
pubmed-meshheading:8067695-Thymidylate Synthase
|
pubmed:articleTitle |
Thymidylate synthase in childhood acute non-lymphoblastic leukemia.
|
pubmed:affiliation |
German Cancer Research Center, Heidelberg.
|
pubmed:publicationType |
Journal Article
|